Form 4: Biocryst Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Vincent Milano, a Director of Biocryst Pharmaceuticals Inc, received 1,159 shares of common stock on August 31, 2026.
Summary
- Grant/award: acquired 1,159 Common Stock at $9.70 ($11,242) on August 31, 2026; holds 109,642 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Vincent Milano — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Grant/award | Common Stock | 1,159 | $10 | $11.2K | 109,642 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Grant/award (1,159 shares) |
Keywords
insider transaction, Form 4, BCRX, BIOCRYST PHARMACEUTICALS INC, neutral, Vincent Milano
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.